Application of comorbidity indexes at baseline could be useful to predict rates of response in patients with chronic myeloid leukemia treated with imatinib
Breccia, Massimo, Salaroli, Adriano, Serrao, Alessandra, Zacheo, Irene, Saracino, Roberta, Alimena, GiulianaVolume:
55
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2013.795650
Date:
January, 2014
File:
PDF, 131 KB
english, 2014